Sight Sciences, Inc.
NASDAQ:SGHT
3.57 (USD) • At close December 20, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Sight Sciences, Inc. |
Symbool | SGHT |
Munteenheid | USD |
Prijs | 3.57 |
Beurswaarde | 181,193,922 |
Dividendpercentage | 0% |
52-weken bereik | 3.16 - 8.45 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. Paul Badawi |
Website | https://www.sightsciences.com |
An error occurred while fetching data.
Over Sight Sciences, Inc.
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)